Cargando…

VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma

Although PD-1/PD-L1 blockade therapy confers salutary effects across cancer types, their efficacy in Extranodal Natural killer/T-cell lymphoma (ENKTCL) patients is limited and unpredictable. Here, we comprehensively evaluated the expression profile of a panel of immune-regulatory makers to identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Hai-Xia, Gao, Yan, Fu, Jian-Chang, Zhou, Qiang-Hua, Wang, Xiao-Xiao, Bai, Bing, Li, Peng-Fei, Huang, Cheng, Rong, Qi-Xiang, Ping, Li-Qin, He, Yan-Xia, Mao, Jia-Ying, Chen, Xu, Huang, Hui-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032243/ https://www.ncbi.nlm.nih.gov/pubmed/33889438 http://dx.doi.org/10.1080/2162402X.2021.1907059

Ejemplares similares

Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy
por: Wang, Hua, et al.
Publicado: (2015)

Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma
por: Huang, Jia-Jia, et al.
Publicado: (2013)

Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma
por: Nie, Man, et al.
Publicado: (2016)

Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
por: Peng, Rou-Jun, et al.
Publicado: (2018)

Correlation between the clinicopathological features and prognosis in patients with extranodal natural killer/T cell lymphoma
por: Zeng, Lin-Shu, et al.
Publicado: (2017)

Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type
por: Wang, Jing-hua, et al.
Publicado: (2017)

Decreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type
por: Quan, Qi, et al.
Publicado: (2016)

Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma
por: Peng, Yin-yin, et al.
Publicado: (2021)

Prognostic Value of the Modified Systemic Inﬂammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma
por: Huang, He, et al.
Publicado: (2020)

Serum C-Reactive Protein (CRP) as a Simple and Independent Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
por: Li, Ya-Jun, et al.
Publicado: (2013)

GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphoma
por: Rong, Qi-xiang, et al.
Publicado: (2021)

Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study
por: Wang, Kefeng, et al.
Publicado: (2017)

The Role of PD-L1 Expression in Prediction and Stratification of Recurrent or Refractory Extranodal Natural Killer/T-Cell Lymphoma
por: Gao, Li-Min, et al.
Publicado: (2022)

Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma
por: Tian, Xiao-Peng, et al.
Publicado: (2023)

Extranodal natural killer/T-cell lymphoma of the tenosynovium of the hand
por: Lim, Yoo Li, et al.
Publicado: (2015)

Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy
por: Li, Yi-Yang, et al.
Publicado: (2016)

Baseline SUVmax of (18)F-FDG PET-CT indicates prognosis of extranodal natural killer/T-cell lymphoma
por: Xia, Xianwu, et al.
Publicado: (2020)

Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma
por: Guo, Hong-Qiang, et al.
Publicado: (2010)

Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database
por: Zheng, Xuan, et al.
Publicado: (2022)

Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase
por: Wang, Liang, et al.
Publicado: (2015)

Treatment of relapsed extranodal natural killer/T-cell lymphoma with bortezomib plus fludarabine
por: Chen, Chen, et al.
Publicado: (2017)

Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
por: Wang, Hua, et al.
Publicado: (2016)

Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
por: Liu, Xin, et al.
Publicado: (2023)

Predicting treatment response of patients with extranodal natural killer/T‐cell lymphoma based on levels of PD‐L1 mRNA and soluble PD‐L1
por: Feng, Yu, et al.
Publicado: (2020)

Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
por: Gill, Harinder, et al.
Publicado: (2010)

Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
por: Althoff, Ashley, et al.
Publicado: (2017)

Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study
por: Zhang, Yuchen, et al.
Publicado: (2021)

Primary extranodal natural killer/T-cell nasal-type lymphoma of spine: A case report
por: Wang, Jie, et al.
Publicado: (2019)

Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement
por: Jin, Xiaoke, et al.
Publicado: (2017)

Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
por: Li, Jia-Ying, et al.
Publicado: (2023)

High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients
por: Wang, Hua, et al.
Publicado: (2016)

PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
por: Bi, Xi-wen, et al.
Publicado: (2016)

A case report of Extranodal natural killer / T-cell lymphoma presenting as extensive myiasis
por: Chih Wong, Eugene Hung, et al.
Publicado: (2022)

Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis
por: Zuhaimy, Hanis, et al.
Publicado: (2017)

Extranodal natural killer/T-cell lymphoma (nasal type) presenting as a perianal abscess: A case report
por: Liu, Yan-Ni, et al.
Publicado: (2019)

Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review
por: Xu, Qing-Yuan, et al.
Publicado: (2022)

Prognostic significance of the systemic immune-inflammation index in patients with extranodal natural killer/T-cell lymphoma
por: Hai, Tao, et al.
Publicado: (2023)

Extranodal natural killer/T cell lymphoma, nasal type in the middle cranial fossa: A case report
por: Wang, Han, et al.
Publicado: (2018)

CD30(+) extranodal natural killer/T-cell lymphoma mimicking phlegmonous myositis: A case report
por: YANG, YAN-JIA, et al.
Publicado: (2014)

Primary Intestinal Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Comprehensive Clinicopathological Analysis of 55 Cases
por: Yu, Bao-Hua, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lorj35ittljbpfl6p0ha4qpd8m